Cargando…
Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer
PURPOSE: To report outcomes following adjuvant high-dose-rate vaginal brachytherapy (VBT) with or without chemotherapy for high-intermediate risk (HIR) and high-risk, early stage endometrial cancer as defined in Gynecologic Oncology Group trial 0249. MATERIAL AND METHODS: From May 2000 to January 20...
Autores principales: | Eldredge-Hindy, Harriet Belding, Eastwick, Gary, Anne, Pramila Rani, Rosenblum, Norman G., Schilder, Russell J., Chalian, Raffi, Zibelli, Allison M., Kim, Christine H., Den, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200177/ https://www.ncbi.nlm.nih.gov/pubmed/25337127 http://dx.doi.org/10.5114/jcb.2014.45031 |
Ejemplares similares
-
Influence of bevacizumab on vaginal cuff evisceration eight months after ovarian cancer cytoreduction surgery: A case report()
por: Skwara, Amanda J., et al.
Publicado: (2013) -
Vaginal cuff brachytherapy: do we need to treat to more than a two-centimeter active length?
por: Jensen, Garrett L., et al.
Publicado: (2021) -
Adjuvant vaginal cuff brachytherapy in surgically treated endometrial carcinoma patients – in view of the recent evidence
por: Serkies, Krystyna, et al.
Publicado: (2021) -
Vaginal cuff dehiscence after intracavitary brachytherapy for endometrial cancer
por: Albuquerque, Kevin, et al.
Publicado: (2012) -
Adjuvant vaginal cuff brachytherapy: dosimetric comparison of conventional versus 3-dimensional planning in endometrial cancer
por: Gultekin, Melis, et al.
Publicado: (2020)